Visitor Monitoring Drug History: HUMULIN N
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: HUMULIN N
FDA Application No: (NDA) 018781
Active Ingredient(s): INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
Company: LILLY
 
Label History
 
View the label approved on August 23, 2007 for HUMULIN N, (NDA) 018781


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
8/22/2007 089Labeling Revision Letter
Label 
9/7/2007 088Labeling Revision Letter 
11/9/2005 085Labeling Revision Letter
Label 
2/25/2005 080Control Supplement Letter
Label 
8/27/2004 079Labeling Revision Letter
Label 
9/3/2004 079Labeling Revision Letter
Label 
4/21/2004 076Labeling Revision Letter
Label 
11/19/2003 074Manufacturing Change or Addition Letter
Label 
6/22/2003 072Labeling Revision Letter
Label 
11/20/2003 070Labeling Revision Letter 
8/29/2002 067Control Supplement  
8/29/2002 066Control Supplement  
8/29/2002 065Control Supplement  
8/21/2002 064Control Supplement  
8/21/2002 063Control Supplement  
10/31/2002 062Control Supplement  
4/2/2002 061Control Supplement  
11/20/2003 060Labeling Revision Letter 
2/12/2003 057Labeling Revision Letter
Label 
7/7/2000 056Manufacturing Change or Addition  
10/29/1999 055Control Supplement  
11/5/2002 054Labeling Revision Letter 
2/25/1999 053Control Supplement  
8/6/1998 050Package Change  
6/24/1997 049Package Change  
2/20/1998 048Control Supplement  
4/16/1997 047Labeling Revision  
1/28/1997 046Manufacturing Change or Addition  
7/10/1996 044Labeling Revision  
7/26/1996 043Control Supplement  
5/22/1996 042Control Supplement  
5/31/1996 041Control Supplement  
1/26/1996 040Manufacturing Change or Addition  
2/15/1996 039Control Supplement  
11/9/1995 038Labeling Revision  
9/29/1995 037Labeling Revision  
3/9/1995 036Control Supplement  
2/22/1995 035Labeling Revision  
2/10/1995 034Manufacturing Change or Addition  
10/27/1995 033Formulation Revision  
12/7/1992 032Package Change  
1/11/1994 031Package Change  
3/12/1991 030Labeling Revision  
9/24/1990 029Control Supplement  
8/17/1990 028Control Supplement  
4/3/1991 027Labeling Revision  
1/23/1989 026Labeling Revision  
7/29/1988 025Control Supplement  
3/3/1988 024Control Supplement  
3/24/1988 023Labeling Revision  
10/27/1987 022Manufacturing Change or Addition  
10/27/1987 021Control Supplement  
10/27/1987 020Manufacturing Change or Addition  
7/10/1987 019Labeling Revision  
7/13/1987 018Labeling Revision  
7/13/1987 017Labeling Revision  
7/28/1987 016Labeling Revision  
10/27/1987 015Formulation Revision  
7/31/1987 014Labeling Revision  
6/28/1988 013Control Supplement  
12/26/1984 010Control Supplement  
2/14/1985 009Control Supplement  
2/29/1984 008Labeling Revision  
7/25/1984 007Control Supplement  
10/12/1983 006Labeling Revision  
8/24/1983 005Labeling Revision  
1/27/1983 004Labeling Revision  
1/31/1983 003Control Supplement  
12/2/1982 002Formulation Revision  
12/2/1982 001Labeling Revision  
10/28/1982 000Approval  
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test